Related references
Note: Only part of the references are listed.Progress towards the development of a P. vivax vaccine
Sai Lata De et al.
EXPERT REVIEW OF VACCINES (2021)
Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells
Benoit Malleret et al.
NATURE MICROBIOLOGY (2021)
Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes
Li-Jin Chan et al.
CELLULAR MICROBIOLOGY (2020)
Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
Camila M. P. Medeiros et al.
PLOS ONE (2020)
Will More of the Same Achieve Malaria Elimination? Results from an Integrated Macroeconomic Epidemiological Demographic Model
Richard D. Smith et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria
Wen-Qiang He et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody
Thomas A. Rawlinson et al.
NATURE MICROBIOLOGY (2019)
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study
Katherine E. Battle et al.
LANCET (2019)
Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax
Jakub Gruszczyk et al.
SCIENCE (2018)
Advancing Research Models and Technologies to Overcome Biological Barriers to Plasmodium vivax Control
Jennifer S. Armistead et al.
TRENDS IN PARASITOLOGY (2018)
Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1(19) subunit proteins in multiplexed serologic assays
Jeffrey W. Priest et al.
MALARIA JOURNAL (2018)
Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region
Camilla Pires et al.
PLOS ONE (2018)
Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions
Rhea J. Longley et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
Francis B. Ntumngia et al.
SCIENTIFIC REPORTS (2017)
Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond
Ken Ing Cherng Ong et al.
BMJ GLOBAL HEALTH (2017)
Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians
Vanessa C. Nicolete et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein
Edwin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy-Positive Reticulocytes
Francis B. Ntumngia et al.
MBIO (2016)
The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants
Flora S. Kano et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Host-parasite interactions that guide red blood cell invasion by malaria parasites
Aditya S. Paul et al.
CURRENT OPINION IN HEMATOLOGY (2015)
Biomarker detection of global infectious diseases based on magnetic particles
Soledad Carinelli et al.
NEW BIOTECHNOLOGY (2015)
Structural Analysis of the Synthetic Duffy Binding Protein (DBP) Antigen DEKnull Relevant for Plasmodium vivax Malaria Vaccine Design
Edwin Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Systematic Review of Sub-microscopic P. vivax Infections: Prevalence and Determining Factors
Qin Cheng et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivax
Simone C. de Cassan et al.
FRONTIERS IN IMMUNOLOGY (2015)
The association of Duffy binding protein region II polymorphisms and its antigenicity in Plasmodium vivax isolates from Thailand
Patchanee Chootong et al.
PARASITOLOGY INTERNATIONAL (2014)
Duffy Antigen Receptor for Chemokine (DARC) Polymorphisms and Its Involvement in Acquisition of Inhibitory Anti-Duffy Binding Protein II (DBPII) Immunity
Flavia A. Souza-Silva et al.
PLOS ONE (2014)
Glycan Masking of Plasmodium vivax Duffy Binding Protein for Probing Protein Binding Function and Vaccine Development
Sowmya Sampath et al.
PLOS PATHOGENS (2013)
Design and Immunogenicity of a Novel Synthetic Antigen Based on the Ligand Domain of the Plasmodium vivax Duffy Binding Protein
Francis B. Ntumngia et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Conserved and Variant Epitopes of Plasmodium vivax Duffy Binding Protein as Targets of Inhibitory Monoclonal Antibodies
Francis B. Ntumngia et al.
INFECTION AND IMMUNITY (2012)
DEVELOPMENT OF QUANTITATIVE RECEPTOR-LIGAND BINDING ASSAY FOR USE AS A TOOL TO ESTIMATE IMMUNE RESPONSES AGAINST Plasmodium vivax DUFFY BINDING PROTEIN REGION II
Ahmad Rushdi Shakri et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2012)
Characterization of Inhibitory Anti-Duffy Binding Protein II Immunity: Approach to Plasmodium vivax Vaccine Development in Thailand
Patchanee Chootong et al.
PLOS ONE (2012)
Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region
Flora S. Kano et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2012)
Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development
Tais Nobrega de Sousa et al.
PLOS ONE (2011)
Current status of Plasmodium vivax vaccine
Myriam Arevalo-Herrera et al.
HUMAN VACCINES (2010)
A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting
Ivor Harris et al.
MALARIA JOURNAL (2010)
Genetic variability and natural selection at the ligand domain of the Duffy binding protein in brazilian Plasmodium vivax populations
Tais N. Sousa et al.
MALARIA JOURNAL (2010)
Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection
I. P. Ceravolo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean Children
Jennifer L. Cole-Tobian et al.
INFECTION AND IMMUNITY (2009)
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Ivo Mueller et al.
LANCET INFECTIOUS DISEASES (2009)
OPENEPI: A WEB-BASED EPIDEMIOLOGIC AND STATISTICAL CALCULATOR FOR PUBLIC HEALTH
Kevin M. Sullivan et al.
PUBLIC HEALTH REPORTS (2009)
Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection
Christopher L. King et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission
I. P. Ceravolo et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens
Genevieve G. Fouda et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Anti-Plasmodium vivax Duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon
IP Ceravolo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2005)
Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135
G Lal et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein
J Xainli et al.
INFECTION AND IMMUNITY (2003)
Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein
P Michon et al.
INFECTION AND IMMUNITY (2000)
Share Paper
